FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. SPY
3. META
4. PSKY
5. VRTX
6. LGND
7. ONON
8. GS
9. MONC:IM
10. PTON

Go back to FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
Amgen Inc (NASDAQ: AMGN) Delayed: 409.29 +16.13 (4.10%)
Previous Close $393.16    52 Week High $176.85 
Open $405.25    52 Week Low $133.64 
Day High $409.30    P/E 61.64 
Day Low $398.52    EPS $6.64 
Volume 1,285,193